General Biologicals

General Biologicals Current Liabilities

The Current Liabilities of General Biologicals (4117.TWO) as of Oct 31, 2026 is 184.36 M TWD. In the previous year, Current Liabilities was 599.51 M TWD — a change of -69.25% (lower).

Current Liabilities

184.36 MTWD

YoY

-69.25%

Last updated:

Current Liabilities of General Biologicals is 2025 184.36 M TWD. Current Liabilities of General Biologicals was 2024 599.51 M TWD. It decreases by -69.25% lower compared to the previous year.

The General Biologicals Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
142.17 M TWD
Jan 1, 2019
131.14 M TWD
Jan 1, 2020
84.83 M TWD
Jan 1, 2021
71.30 M TWD
Jan 1, 2022
119.23 M TWD
Jan 1, 2023
1.14 B TWD
Jan 1, 2024
599.51 M TWD
Jan 1, 2025
184.36 M TWD
The General Biologicals Current Liabilities history
YEARCurrent LiabilitiesYoY
184.36 MTWD-69.25%
599.51 MTWD-47.51%
1.14 BTWD+857.95%
119.23 MTWD+67.21%
71.30 MTWD-15.94%
84.83 MTWD-35.32%
131.14 MTWD-7.75%
142.17 MTWD+7.53%
132.21 MTWD+79.38%
73.70 MTWD+57.32%
46.85 MTWD+17.30%
39.94 MTWD-20.84%
50.45 MTWD+22.42%
41.21 MTWD-8.42%
45.00 MTWD-20.86%
56.86 MTWD+6.55%
53.37 MTWD+6.35%
50.18 MTWD-22.91%
65.09 MTWD+3.41%
62.95 MTWD+16.28%
54.14 MTWD-3.89%
56.32 MTWD+27.27%
44.26 MTWD+12.81%
39.23 MTWD-22.11%
50.36 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

General Biologicals Stock analysis

What does General Biologicals do? General Biologicals Corp., headquartered in Baoshan, Hsinchu, Taiwan, operates in the Health Care sector, specifically within the Biotechnology industry. The company engages in research, development, manufacturing, and trading of diagnostics, pharmaceuticals, and medical supplies. Its main products include detection reagents, biological protein new drugs, P113, and medical supplies, distributed domestically and internationally. Listed on 4 July 2002, the company employs 63 people. General Biologicals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about General Biologicals stock

Current Liabilities of General Biologicals is 184.36 M TWD in 2025.

Current Liabilities of General Biologicals changed from 599.51 M TWD to 184.36 M TWD, representing a -69.25% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities General Biologicals since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's General Biologicals historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — General Biologicals

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — General Biologicals